Eli Lilly to create 2,000 construction jobs in Pennsylvania with $3.5bn new facility

Eli Lilly and Company has broken ground on a $3.5bn manufacturing facility in Pennsylvania’s Lehigh Valley.

The site is one of 10 new US manufacturing sites announced since 2020 and one of four among them dedicated to injectable medicines and devices.

Part of the company’s $50bn push to expand medicine production in the US, the Lehigh Valley site will add capacity for the next generation of obesity treatments, including retatrutide, a first-in-class investigational GIP, GLP-1 and glucagon triple hormone receptor agonist…

Story continues

TRENDING NOW

LATEST LOCAL NEWS